Cours Generex Biotechnology Corporation OTC Bulletin Board
Actions
US3714851033
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
2022 | Requête involontaire approuvée pour Generex Biotechnology Corporation | CI |
2022 | Pétition involontaire déposée contre Generex Biotechnology Corporation | CI |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joseph Moscato
CEO | Chief Executive Officer | 61 | 21/11/17 |
Mark Carrao
DFI | Director of Finance/CFO | - | 01/01/17 |
Terry Thompson
COO | Chief Operating Officer | 65 | 25/06/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Brian T. McGee
BRD | Director/Board Member | 63 | 01/03/04 |
Eric von Hofe
PRN | Corporate Officer/Principal | 66 | 01/01/05 |
Craig Eagle
BRD | Director/Board Member | 57 | 21/11/17 |
Varia. 1 janv. | Capi. | |
---|---|---|
+11,91% | 118 Md | |
+11,60% | 106 Md | |
-4,68% | 24,28 Md | |
-0,82% | 21,96 Md | |
-10,12% | 18,16 Md | |
-42,12% | 16,37 Md | |
-17,47% | 15,56 Md | |
+2,77% | 13,63 Md | |
+34,58% | 12,27 Md |
- Bourse
- Actions
- Action GNBT
- Action